Clinical cure of acute hepatitis B virus infection-related liver failure with HBsAg seroconversion： A case report

Xufeng QUAN; Shue XIONG; Wenqing ZHOU; Ruxia ZHOU; Jia LIU; Xin ZHENG

doi:10.12449/JCH240724

Volume 40 Issue 7

Jul. 2024

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(7): 1446-1449

PDF( 851 KB)

Clinical cure of acute hepatitis B virus infection-related liver failure with HBsAg seroconversion： A case report

DOI: 10.12449/JCH240724

1.
Department of Infectious Diseases，Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology，Wuhan 430022，China
2.
Hubei Jiangxia Laboratory，Wuhan 430200，China

Research funding:

National Key Research and Development Program of China (2022YFC2305100);

National Natural Science Foundation of China (92169121);

Wuhan Institute of Virology, CAS (JXBS001)

More Information

Corresponding author: ZHENG Xin， xinz@hust.edu.cn （ORCID： 0000-0001-6564-7807）
Received Date: 2023-11-16
Accepted Date: 2023-12-25
Published Date: 2024-07-25

Abstract

Abstract

About 1% of the patients with acute hepatitis B can progress to acute liver failure， and 75% of the patients with hepatitis B virus （HBV）-related acute liver failure need to undergo liver transplantation or face death. This article reports a patient with HBV infection-related acute liver failure who achieved clinical cure and HBsAg seroconversion after antiviral therapy and symptomatic/supportive treatment， and dynamic monitoring was performed for immunological markers in peripheral blood.
- Liver Failure， Acute,
- Hepatitis B virus,
- Immunity

FullText(HTML)

References(11)

References

[1]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[2]	LIANG TJ. Hepatitis B: The virus and disease[J]. Hepatology, 2009, 49( 5 Suppl): S13- S21. DOI: 10.1002/hep.22881.
[3]	JIA JD, WEI L, HOU JL, et al. Chinese standards for diagnosis and treatment of liver disease-White paper excerpt[J]. J Clin Hepatol, 2014, 30( 3): 197- 209. DOI: 10.3969/j.issn.1001-5256.2014.03.002. 贾继东, 魏来, 侯金林, 等.《中国肝病诊疗管理规范》白皮书(节选)[J]. 临床肝胆病杂志, 2014, 30( 3): 197- 209. DOI: 10.3969/j.issn.1001-5256.2014.03.002.
[4]	GUIDOTTI LG, ISOGAWA M, CHISARI FV. Host-virus interactions in hepatitis B virus infection[J]. Curr Opin Immunol, 2015, 36: 61- 66. DOI: 10.1016/j.coi.2015.06.016.
[5]	KONDO Y, KOBAYASHI K, ASABE S, et al. Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8 T lymphocytes in fulminant hepatitis B[J]. Liver Int, 2004, 24( 6): 561- 567. DOI: 10.1111/j.1478-3231.2004.0982.x.
[6]	CHEN ZC, DIAZ G, POLLICINO T, et al. Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure[J]. Proc Natl Acad Sci U S A, 2018, 115( 48): E11369- E11378. DOI: 10.1073/pnas.1809028115.
[7]	SHINGINA A, MUKHTAR N, WAKIM-FLEMING J, et al. Acute liver failure guidelines[J]. Am J Gastroenterol, 2023, 118( 7): 1128- 1153. DOI: 10.14309/ajg.0000000000002340.
[8]	ZHANG Z, ZHANG JY, WHERRY EJ, et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B[J]. Gastroenterology, 2008, 134( 7): 1938- 1949. DOI: 10.1053/j.gastro.2008.03.037.
[9]	KHAN AR, HAMS E, FLOUDAS A, et al. PD-L1hi B cells are critical regulators of humoral immunity[J]. Nat Commun, 2015, 6: 5997. DOI: 10.1038/ncomms6997.
[10]	XIONG SE, ZHU D, LIANG BY, et al. Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss[J]. EBioMedicine, 2021, 69: 103464. DOI: 10.1016/j.ebiom.2021.103464.
[11]	SPRENGERS D, van der MOLEN RG, KUSTERS JG, et al. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans[J]. J Hepatol, 2006, 45( 2): 182- 189. DOI: 10.1016/j.jhep.2005.12.022.

Relative Articles

[1]	Lu YE, Fan ZHAO, Qianqian HUANG, Jiayi ZHANG, Jianqing WANG. Menaquinone-4 exerts a protective effect against carbon tetrachloride-induced acute liver injury in mice by alleviating ferroptosis[J]. Journal of Clinical Hepatology, 2024, 40(1): 121-128. doi: 10.12449/JCH240121
[2]	Haimei GUAN, Kan ZHANG, Weiyu CHEN, Guobao LI, Yangling ZENG, Riyun ZHANG, Tianwen WANG, Baohua XIE, Dewen MAO. Mechanism of action and potential value of the IRE1α/TRAF2/JNK pathway in the progression of acute liver failure[J]. Journal of Clinical Hepatology, 2024, 40(6): 1281-1288. doi: 10.12449/JCH240633
[3]	Yu WANG, Qiong LUO, Shu LI, Xiaoping SHEN, Shuang LI, Yanyan TAO, Chenghai LIU. A preliminary study on the peripheral seroimmunological characteristics of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2022, 38(5): 1097-1100. doi: 10.3969/j.issn.1001-5256.2022.05.023
[4]	Ma WeiYu, Deng ZhiHua. Current status of immunogenetic studies on primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 932-935. doi: 10.3969/j.issn.1001-5256.2020.04.050
[5]	Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Chinese Society of Perinatal Medicine, Chinese Medical Association. 2020 clinical guidelines on prevention of mother-to-child transmission of hepatitis B virus[J]. Journal of Clinical Hepatology, 2020, 36(7): 1474-1481. doi: 10.3760/cma.j.cn112141-20200213-00101
[6]	Cui FuQiang. Hepatitis B vaccine immunization is the key strategy for prevention of HBV mother-to-child transmission——Comments on 2019 Chinese practice guideline for the prevention and treatment of hepatitis B virus mother-to-child transmission[J]. Journal of Clinical Hepatology, 2020, 36(2): 305-306. doi: 10.3969/j.issn.1001-5256.2020.02.012
[7]	Hao DaAng, Liu Ye, Shen ShanShan, Yan XueBing. An excerpt of AISF position paper on HCV in immunocompromised patients (2018)[J]. Journal of Clinical Hepatology, 2019, 35(4): 755-761. doi: 10.3969/j.issn.1001-5256.2019.04.010
[8]	Jiang YingYing, Zhang XiaoHui, Zheng SuJun. Change in immune status after antiviral therapy in patients with hepatitis C virus infection[J]. Journal of Clinical Hepatology, 2018, 34(2): 403-406. doi: 10.3969/j.issn.1001-5256.2018.02.041
[9]	Qin Wei, Zhao CaiYan, Yang Zhao, Zhu SuPing, Li MuSong, Huo YuLing. Research advances in the role of OX40/OX40L in the immune pathogenesis of chronic hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(5): 1103-1106. doi: 10.3969/j.issn.1001-5256.2018.05.038
[10]	Zhu JuanJuan, Cheng MingLiang, Zhao XueKe. Role of liver immunological inflammation in development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2016, 32(3): 570-573. doi: 10.3969/j.issn.1001-5256.2016.03.038
[11]	Wang WeiBin, Li YongYin, Hou JinLin. Features of immune response during antiviral therapy in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(10): 1858-1862. doi: 10.3969/j.issn.1001-5256.2016.10.007
[12]	Jia ZhanSheng, Lian JianQi. Improving understanding of liver immune function and enhancing research on cell therapy for liver diseases[J]. Journal of Clinical Hepatology, 2014, 30(9): 839-841. doi: 10.3969/j.issn.1001-5256.2014.09.001
[13]	Zhang Zheng, Wang FuSheng. Current perspectives on immune pathogenesis and immune therapy of chronic hepatitis B [J]. Journal of Clinical Hepatology, 2012, 28(11): 801-804.
[15]	Xie Fang, Lin ZunHui, Jin HaiYing, Guo XiangHua, Huang YanXiang, Yin JiMing, Yan Yan, Hao Wa, Niu JingQin, Li Zhuo. The applied value of Dane granule antigen of hepatitis B viral in detecting chronic hepatitis B infection[J]. Journal of Clinical Hepatology, 2007, 23(6): 415-417.
[16]	Chen Sheng, Lin ChaoShuang. The relationship between liver function and immune system and viral replication in patients with viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 94-95.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (330) PDF downloads(53)

Clinical cure of acute hepatitis B virus infection-related liver failure with HBsAg seroconversion： A case report

DOI: 10.12449/JCH240724

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Clinical cure of acute hepatitis B virus infection-related liver failure with HBsAg seroconversion： A case report

DOI: 10.12449/JCH240724

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content